Trevena

Trevena

Trevena

Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Founded
2007
Raised
$164M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$45,000,000
Post-IPO equity - 2014
$60,000,000
Venture capital (Series C) - 2013
Forest Laboratories
Team Size
10+
Employees
the home of AI info

Trevena Inc. (TRVN)'s Financial Results Comparing With Minerva Neurosciences Inc. (NASDAQ ...

The Motley Fool

Here's Why Trevena Stock Dropped 18% Today

The Motley Fool

Why Trevena Inc.'s Shares Broke Through Today

Health Stock markets